Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
QIAGEN - GeneGlobe Pathways - Mitotic Roles of Polo Like Kinases
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Structure and function of the human Polo-like kinases: (A) Polo-like... | Download Scientific Diagram
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Polo-Like Kinase-1 | SpringerLink
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
PLK1 - Wikipedia
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology
The polo-like kinase family. Schematic representation of the five... | Download Scientific Diagram
Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS - Cell Chem. Bio. - X-MOL
Putting a bit into the polo-box domain of polo-like kinase 1 | SpringerLink
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The Polo-like Kinase Inhibitor
Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy - Eur. J. Med. Chem. - X-MOL
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research
